Navidea Biopharmaceutica (Israel) Price Prediction and Hype Density Breakdown

NAVB -- Israel Stock  

ILS 73.10  4.90  6.28%

We analyze noise-free headlines and recent hype associated with Navidea Biopharmaceuticals which may create opportunities for some arbitrage if properly timed. With Navidea Biopharmaceutica hype-based prediction module you can estimate the value of Navidea Biopharmaceuticals from the prospective of Navidea Biopharmaceutica response to recently generated media hype and the effects of current headlines on its competitors. The module also provides analysis of price elasticity to changes in media outlook on Navidea Biopharmaceutica over a specific investment horizon. Please see also Stocks Correlation.
Horizon     30 Days    Login   to change

Navidea Biopharmaceutica After-Hype Price Density Analysis

 Next price density 
      Expected price to next headline 

Navidea Biopharmaceutica Estimiated After-Hype Price Volatility

December 11, 2018
Current Value
After-hype Price
Target Odds
Navidea Biopharmaceutica is Unknown risk asset. Analysis and calculation of next after-hype price of Navidea Biopharmaceutica is based on 2 months time horizon.

Navidea Biopharmaceutica Next Price Analysis

Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 4.66% 4.99% 0.00%  4.05% 0 Events / Month4 Events / MonthUncertain
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

Navidea Biopharmaceutica Hype Timeline

Navidea Biopharmaceuticals is now traded for 73.10on Tel Aviv Stock Exchange of Israel. This company stock is not elastic to its hype. The average elasticity to hype of competition is 4.05. Navidea Biopharmaceuticals is anticipated not to react to the next headline with price going to stay at about the same level and average media hype impact volatility of 0.0%. The immediate return on the next news is anticipated to be very small where as daily expected return is now at -4.66%. The volatility of relative hype elasticity to Navidea Biopharmaceutica is about 573.56%%. The volatility of related hype on Navidea Biopharmaceutica is about 573.56% with expected price after next announcement by competition of 77.15. About 35.0% of the company shares are owned by institutional investors. The company has Price/Earnings (P/E) ratio of 197.2. Navidea Biopharmaceuticals recorded loss per share of 0.09. This company had not issued any dividends in recent years. Assuming 30 trading days horizon, the next anticipated press release will be uncertain.
Please see also Stocks Correlation.

Navidea Biopharmaceutica Related Hype Analysis

At Risk
Oil Refineries Ltd 4.70 7 per month 0.00  0.0482  2.63 (2.85)  7.03 
Bank Leumi le Israel B M 0.00 0 per month 1.14  0.19  1.80 (1.65)  5.45 
Perrigo Company plc 30.00 4 per month 0.00 (0.06)  3.35 (3.31)  14.43 
Israel Chemicals Ltd(12.00) 1 per month 2.54  0.13  3.78 (4.28)  10.61 
NICE Ltd(440.00) 5 per month 1.77  0.13  2.64 (2.90)  7.15 
Azrieli Group Ltd(150.00) 1 per month 1.09  0.15  1.88 (1.88)  6.68 
Elbit Systems Ltd 600.00 4 per month 0.00  0.08  3.18 (3.41)  8.84 
Mizrahi Tefahot Bank Ltd(11.00) 3 per month 1.02  0.21  1.98 (1.90)  4.27 
Israel Discount Bank Limited 1.00 2 per month 0.00  0.07  2.44 (3.01)  6.98 
Delek Drilling Limited Partnership(14.00) 1 per month 1.39  0.15  3.06 (2.79)  7.77 

Latest Stories

Recently Published Macroaxis Stories

Investors are also interested in

Purchased over 50 shares
Active few hours ago
Please see also Stocks Correlation. Please also try Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.